AVANT GUARD Study: Early Ablation for Persistent Atrial Fibrillation

Walid Saliba, MD, and Oussama Wazni, MD, discuss the design and outcomes of the AVANT GUARD study evaluating first-line pulsed field ablation in drug-naive patients with persistent atrial fibrillation. The conversation explores efficacy endpoints, safety findings, and the implications for early rhythm control and disease progression.Read more about the study. https://consultqd.clevelandclinic.org/pulsed-field-ablation-for-initial-treatment-of-persistent-afLooking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.